India, Nov. 20 -- India has made significant progress against tuberculosis (TB), with the incidence of the disease declining 21% since 2015, to 187 per 100,000 people, according to the WHO Global Tuberculosis Report 2025. Yet India still accounted for 32% of the world's estimated multidrug- and rifampicin-resistant TB cases in 2024. Hence, the challenge today is no longer just finding infections, but knowing precisely, and early which drugs are likely to work.

The Cost of Uncertainty

When a person with persistent cough reaches a clinic, a chest X-ray may indicate the possibility of pulmonary TB. But further testing is needed to confirm it. For this, sputum samples are sent to the lab, and if it shows resistance to rifampicin (a key firs...